EX-23.2 4 v029962_ex23-2.htm
EXHIBIT 23.2
 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
 
Securities and Exchange Commission
Washington, DC
 
We consent to the use in this Registration Statement of ZIOPHARM Oncology, Inc. (formerly EasyWeb, Inc.) on Form SB-2, of our report dated February 19, 2005, appearing in the Prospectus.
 
We also consent to the reference to us under the heading “Experts” in such Prospectus.
     
   
 
 
 
 
 
 
Date: November 22, 2005    /s/ Cordovano and Honeck LLP
 
Cordovano and Honeck LLP
  Denver, Colorado